BioLight Announces New Investment in Development of Ophthalmic Drugs

BioLight announced its investment in a newly-formed ophthalmic company that has licensed-in a world-wide drug-delivery platform from the Hebrew University, Israel, that has the potential to enable more efficient and safer delivery of eye drops.

Link to complete article

Link to Newsroom

Comments are closed.